Search - tctmd.com

Displaying 41 - 60 of 66

Sort: Relevancy | Date

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

News Daily News

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

November 01, 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

October 04, 2019

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Presentation TCT 2019

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Presenter: Kishore Harjai

September 27, 2019

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Presentation TCT 2019

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Presenter: Simon Cheung-chi Lam

September 27, 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

September 11, 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

September 10, 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

News Conference News EuroPCR 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

May 31, 2019

Device-Related Thrombus and LAA Closure: Rare but Dangerous

News Daily News

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Yael L. Maxwell

May 09, 2019

Novel LAA Closure Device Shows Promise in Early Experience

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

September 22, 2018

TCT-102: Incidence, Predictors and Outcomes of Device-Related Thrombus After Left Atrial Appendage Closure With The WATCHMAN Device. Insights From the EWOLUTION Real World Registry

Presentation TCT 2018

TCT-102: Incidence, Predictors and Outcomes of Device-Related Thrombus After Left Atrial Appendage Closure With The WATCHMAN Device. Insights From the EWOLUTION Real World Registry

Presenter: Sameer Gafoor, David R. Holmes Jr., Alexander Sedaghat

September 21, 2018

TCTMD’s Top 10 Most Popular Stories for May 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

June 01, 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

News Conference News HRS 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

May 14, 2018

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

News Daily News

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

April 03, 2018

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Presentation TCT 2017

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Presenter: Matthew J. Price, Jacqueline Saw, Lucas V. Boersma

October 31, 2017

News Industry News

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

September 05, 2017

News Daily News

Thrombus Relatively Common After LAA Occlusion With Amplatzer Amulet, Small Study Suggests

July 28, 2016

News Daily News

Percutaneous Interatrial Shunts May Offer New Hope for Advanced Heart Failure Patients

March 29, 2016

News Conference News ISET 2016

Aspiration Thrombectomy Restores Flow in Patients With Peripheral Arterial Occlusion: PRISM Registry

Michael O'Riordan

February 09, 2016

News Daily News

Latest Watchman Design Appears Safer, More User-Friendly

Yael L. Maxwell

September 16, 2015

News Conference News EuroPCR 2014

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

May 22, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.